Centrum Badawczo – Rozwojowe Novasome limited liability company as part of the Consortium is implementing a project co-financed from European Funds entitled “Development of an innovative pilot line and its validation in real conditions using the model synthesis of the active substance.” Project no. POIR.01.01.01-00-0072 / 21 is implemented under the Smart Growth Operational Program 2014-2020, Priority Axis I “Support for R&D by enterprises”, Sub-measure 1.1.1 enterprises. The aim of the project is to develop a technological innovation and its verification in real conditions on the pilot kilo-lab line, enabling efficient and safe synthesis of active pharmaceutical substances (API). The scope of the project covers, inter alia, designing a technological installation that will enable a wide range of synthesis processes and monitoring of the course of individual reactions “on-line”.

We are open to all models of cooperation. We adapt to the client’s needs.